ChemoCentryx, Inc. Deferred Revenue
ChemoCentryx, Inc. had Deferred Revenue of $21.02 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-08-08
- 2022-06-30: Deferred Revenue, Current $21.02M.
- 2022-03-31: Deferred Revenue, Current $18.71M.
- 2021-12-31: Deferred Revenue, Current $10.99M.
- 2021-09-30: Deferred Revenue, Current $15.62M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-06-30 | $21.02M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $18.71M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $10.99M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $15.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $10.62M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $13.04M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $12.59M 10-K · filed 2022-03-01 |
| 2020-09-30 | $9.82M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $27.50M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $40.76M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $37.74M 10-K · filed 2021-03-01 |
| 2019-09-30 | $36.82M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $41.12M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $51.95M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $50.46M 10-K · filed 2020-03-10 |
| 2018-09-30 | $49.02M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $56.67M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $69.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $22.96M 10-K · filed 2019-03-11 |
| 2017-09-30 | $34.87M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $34.87M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $34.87M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $29.02M 10-K · filed 2018-03-12 |
| 2016-09-30 | $18.17M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $15.72M 10-Q · filed 2016-08-09 |